Acute Leukemia of Ambiguous Lineage: Diagnosis and Evaluation by Flow Cytometry

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2025 Mar 13

PMID 40075717

Authors

Franklin Fuda

Weina Chen

Affiliations

Soon will be listed here.

Abstract

Acute leukemia of ambiguous lineage (ALAL) includes mixed-phenotype acute leukemia (MPAL), which exhibits immunophenotypic evidence of differentiation along more than one cell lineage, and acute undifferentiated leukemia (AUL), which lacks sufficient immunophenotypic differentiation along any cell lineage. This review provides an overview of ALAL, emphasizing the central role of flow cytometric analysis in its diagnostic workflow. It primarily focuses on MPAL, addressing updated classification and diagnostic criteria by the WHO-HEM5 and the ICC, including both genetically defined and phenotypically defined MPAL. The article provides a detailed review of the MPAL lineage assignment criteria with an illustrative description of a series of MPAL cases. Future studies are needed to reconcile the different criteria used in these two classifications. Continuously expanded molecular studies are expected to provide a genomic and lineage-associated framework for the classification of ALAL with clinical relevance in the diagnosis and therapy selection.

References

Patkar N, Bhanshe P, Rajpal S, Joshi S, Chaudhary S, Chatterjee G . NARASIMHA: Novel Assay based on Targeted RNA Sequencing to Identify ChiMeric Gene Fusions in Hematological Malignancies. Blood Cancer J. 2020; 10(5):50. PMC: 7200652. DOI: 10.1038/s41408-020-0313-6. View

Galera P, Dilip D, Derkach A, Chan A, Zhang Y, Persaud S . Defining 2 Biologically and Clinically Distinct Groups in Acute Leukemia with a Mixed Phenotype. Blood. 2025; . DOI: 10.1182/blood.2024026273. View

Wang Q, Cai W, Wang Q, Zhu M, Yan L, Yu Y . Integrative genomic and transcriptomic profiling reveals distinct molecular subsets in adult mixed phenotype acute leukemia. Am J Hematol. 2022; 98(1):66-78. DOI: 10.1002/ajh.26758. View

Klairmont M, Choi J . Mixed-phenotype acute leukemia, T/megakaryoblastic. Blood. 2018; 132(22):2418. DOI: 10.1182/blood-2018-09-871194. View

Oberley M, Li S, Orgel E, Wee C, Hagiya A, OGorman M . Clinical Significance of Isolated Myeloperoxidase Expression in Pediatric B-Lymphoblastic Leukemia. Am J Clin Pathol. 2017; 147(4):374-381. DOI: 10.1093/ajcp/aqx021. View

Khanlari M, Wang L, Bolen C, Otanez F, Furtado L, Key L . -positive acute leukemia with RAM and mixed T/megakaryocytic phenotype. EJHaem. 2023; 4(3):765-769. PMC: 10435670. DOI: 10.1002/jha2.741. View

Fuda F, Chen M, Chen W, Cox A . Artificial intelligence in clinical multiparameter flow cytometry and mass cytometry-key tools and progress. Semin Diagn Pathol. 2023; 40(2):120-128. DOI: 10.1053/j.semdp.2023.02.004. View

Ng D, Simonson P, Tarnok A, Lucas F, Kern W, Rolf N . Recommendations for using artificial intelligence in clinical flow cytometry. Cytometry B Clin Cytom. 2024; 106(4):228-238. DOI: 10.1002/cyto.b.22166. View

Bene M, Porwit A . Mixed Phenotype/Lineage Leukemia: Has Anything Changed for 2021 on Diagnosis, Classification, and Treatment?. Curr Oncol Rep. 2022; 24(8):1015-1022. PMC: 9249706. DOI: 10.1007/s11912-022-01252-w. View

10.

Hirabayashi S, Ohki K, Nakabayashi K, Ichikawa H, Momozawa Y, Okamura K . ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype. Haematologica. 2016; 102(1):118-129. PMC: 5210242. DOI: 10.3324/haematol.2016.151035. View

11.

Brestoff J . Full spectrum flow cytometry in the clinical laboratory. Int J Lab Hematol. 2023; 45 Suppl 2:44-49. PMC: 10330381. DOI: 10.1111/ijlh.14098. View

12.

Matutes E, Pickl W, Veer M, Morilla R, Swansbury J, Strobl H . Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification. Blood. 2011; 117(11):3163-71. DOI: 10.1182/blood-2010-10-314682. View

13.

Fuda F, Chen W . Lineage determination in mixed phenotype acute leukemia: response to Marcondes et al. Cytometry B Clin Cytom. 2014; 86(3):150-1. DOI: 10.1002/cyto.b.21159. View

14.

Zheng R, Fuda F, Gagan J, Weinberg O, Koduru P, Cantu M . Genomic heterogeneity within B/T mixed phenotype acute leukemia in a context of an immunophenotype. Leuk Res Rep. 2024; 21:100410. PMC: 10808966. DOI: 10.1016/j.lrr.2023.100410. View

15.

Choi S, Frederiksen J, Ross C, Bixby D, Shao L . Philadelphia Chromosome-like Mixed-Phenotype Acute Leukemia Demonstrating P2RY8-CRLF2 Fusion and JAK1 Mutation. Am J Clin Pathol. 2017; 148(6):523-528. DOI: 10.1093/ajcp/aqx111. View

16.

Montefiori L, Mullighan C . Redefining the biological basis of lineage-ambiguous leukemia through genomics: BCL11B deregulation in acute leukemias of ambiguous lineage. Best Pract Res Clin Haematol. 2021; 34(4):101329. PMC: 8649174. DOI: 10.1016/j.beha.2021.101329. View

17.

Khoury J, Solary E, Abla O, Akkari Y, Alaggio R, Apperley J . The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia. 2022; 36(7):1703-1719. PMC: 9252913. DOI: 10.1038/s41375-022-01613-1. View

18.

Liu Y, Easton J, Shao Y, Maciaszek J, Wang Z, Wilkinson M . The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. Nat Genet. 2017; 49(8):1211-1218. PMC: 5535770. DOI: 10.1038/ng.3909. View

19.

Weinberg O, Dennis J, Zia H, Chen P, Chu A, Koduru P . Adult mixed phenotype acute leukemia (MPAL): B/myeloid MPAL is distinct from other MPAL subtypes. Int J Lab Hematol. 2022; 45(2):170-178. DOI: 10.1111/ijlh.13988. View

20.

Wang W, Beird H, Kroll C, Hu S, Bueso-Ramos C, Fang H . T(6;14)(q25;q32) involves BCL11B and is highly associated with mixed-phenotype acute leukemia, T/myeloid. Leukemia. 2020; 34(9):2509-2512. DOI: 10.1038/s41375-020-0761-9. View